Welcome to the new version of CaltechAUTHORS. Login is currently restricted to library staff. If you notice any issues, please email coda@library.caltech.edu
Published August 2009 | public
Journal Article

Correction of Myopia after Cataract Surgery with a Light-Adjustable Lens


Purpose: To determine whether residual myopia could be corrected postoperatively using the light-adjustable lens (LAL) technology in patients undergoing cataract surgery and LAL implantation. Design: A prospective clinical study was conducted at Codet Vision Institute in Tijuana, Mexico. The LALs were implanted that would purposely result in myopic errors of up to -1.5 D (diopter). The LAL was treated with a spatial intensity profile delivered by a digital light delivery device to induce a targeted myopic refractive change. Once the desirable myopic correction was achieved, the LAL was treated again to lock-in the lens power. Participants: Fourteen eyes of 14 patients were studied. Methods: The manifest refraction, uncorrected visual acuity (UCVA), and best- or spectacle-corrected visual acuity (BCVA), were measured with follow up time of 1 to 9 months to determine the achieved refractive corrections and their stability. Main Outcome Measures: We measured UCVA and BCVA, achieved versus targeted refractive outcome, and refractive stability with follow up time of 1 to 9 months. Results: Of 14 eyes, 13 eyes (92.9%) achieved 0.25 D of the target refraction at 1 day post lock-in with 100% of the eyes achieving the targeted refractive adjustment within 0.5 D or better with up to 9 months postoperative follow-up. All eyes treated show no change in manifest spherical refraction ›0.25 D between 1 day post lock-in, and 3, 6, and 9 months postoperative visits. The data demonstrate the stability of the achieved refractive change after the adjustment and lock-in procedures. The mean rate of change was 0.006 D per month, which is 6 times more stable than that of laser corneal refractive procedures. Conclusions: Residual myopia errors up to -1.5 D were successfully corrected with precision and significant improvement in UCVA and without compromising BCVA using the LAL technology.

Additional Information

© 2009 American Academy of Ophthalmology. Originally received: May 30, 2008. Final revision: January 14, 2009. Accepted: February 11, 2009. Available online: June 4, 2009. Financial Disclosure(s): The authors (CS, SC, BT) are Calhoun Vision employees. PR is a former Calhoun Vision employee. AC is the clinical investigator for Calhoun Vision, compensated only for his typical surgery fee for each patient, with no financial interest. DS and RG are both Founding Scientists and a Board Member of Calhoun Vision with financial interest. Supported by SBIR grant EY12181-02.

Additional details

August 20, 2023
October 18, 2023